Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?

Margherita Giannini; Mickael Ohana; Benoit Nespola; Giovanni Zanframundo; Bernard Geny; Alain Meyer

doi:10.1183/13993003.01618-2020

Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?

Eur Respir J. 2020 Sep 24;56(3):2001618. doi: 10.1183/13993003.01618-2020. Print 2020 Sep.

Authors

Margherita Giannini¹, Mickael Ohana², Benoit Nespola³, Giovanni Zanframundo^{4

5}, Bernard Geny^{1

6}, Alain Meyer^{7

6

8}

Affiliations

¹ Physiology and Functional Explorations Dept, University Hospitals of Strasbourg, Strasbourg, France.
² Radiology Dept, Nouvel Hôpital Civil, University Hospitals of Strasbourg, Strasbourg, France.
³ Laboratory of Immunology, Nouvel Hôpital Civil, University Hospitals of Strasbourg, Strasbourg, France.
⁴ Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
⁵ Dept of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.
⁶ Federation of Translational Medicine of Strasbourg, Strasbourg University, Strasbourg, France.
⁷ Physiology and Functional Explorations Dept, University Hospitals of Strasbourg, Strasbourg, France alain.meyer1@chru-strasbourg.fr.
⁸ Rheumatology Dept, National Centre for Rare Systemic Autoimmune Diseases, University Hospitals of Strasbourg, Strasbourg, France.

Abstract

Similarities between COVID-19 and anti-MDA5 syndrome support further evaluation of employing an immunomodulatory strategy in COVID-19 https://bit.ly/3dN6lJ8

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
COVID-19
Calcinosis
Coronavirus Infections*
Cytokines*
Heart Valve Diseases
Hypotrichosis
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Skin Diseases, Genetic

Substances

Cytokines

Supplementary concepts

Storm Syndrome